Investing in the Startup Nation: A Look at Israel's Innovation-Focused ETF

Analyzing the ARK Israel ETF (IZRL): a low-cost, equal-weighted fund offering diversified exposure to Israel's leading tech and biotech innovators.

For years, Israel has earned its reputation as a global "Startup Nation," with particular strengths in biotechnology and information technology. The ARK Israel Innovative Technology ETF (IZRL) packages this economic dynamism into a single, passive investment vehicle, offering targeted exposure to disruptive companies. As of early April 2026, this fund provides a concentrated gateway to one of the world's most vibrant innovation hubs, with assets under management of approximately $127 million.

Competitive Edge and Fund Mechanics

A key advantage for the IZRL lies in its cost structure. The fund's expense ratio of 0.49% is notably lower than competing products, such as the BlueStar Israel Technology ETF (ITEQ), which charges 0.75%. Over the long term, this fee differential can have a meaningful impact on net returns for investors.

The ETF's internal activity is reflected in a turnover rate that reached 56% in February 2026. This dynamism stems from a quarterly rebalancing strategy designed to maintain an equal-weighted portfolio. By preventing any single holding from becoming overly dominant, this approach ensures the fund stays true to its diversified, thematic mandate.

Portfolio Composition and Diversification

Technology forms the core of the ETF's holdings, accounting for nearly half of the portfolio. The healthcare sector follows with a weighting of about 20%, while communication services make up roughly 13%. The fund holds 63 distinct positions, and its top ten holdings represent just 22.5% of total assets. This broad diversification is a direct result of the equal-weighting methodology applied to the underlying index constituents.

Forward Perspective

The coming months will reveal how global trends in medical technology and software development impact the Israeli heavyweights within the fund's portfolio. With its quarterly rebalancing schedule, the next adjustments to the portfolio's composition are imminent. Furthermore, the flow of capital into thematic ETFs like the IZRL serves as a barometer for investor confidence in the region's ongoing innovative capacity.